Meridian Bioscience, Inc. Profile Avatar - Palmy Investing

Meridian Bioscience, Inc.

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates thro…
Medical - Diagnostics & Research
US, Cincinnati [HQ]

Cash Flow Statement

14 Sheets · From 2022 to 2009
Configuration
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Operating Activities
Operating Cash Flow (OCF)
32.00 31.00 22.00 42.00 44.00 38.00 42.00 37.00 41.00 34.00 35.00 47.00 66.00 82.00
Operating Cash (Net)
32.00 31.00 22.00 42.00 44.00 38.00 42.00 37.00 41.00 34.00 35.00 47.00 66.00 82.00
Accounts Receivable
-5.00 - - - - - - - - - - - - - - - - -4.00 -2.00 - - -12.00 4.00
Accounts Payable
- - - - - - - - - - - - - - - - - - 4.00 -2.00 7.00 6.00 1.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-3.00 -17.00 -9.00 -4.00 -3.00 -7.00 -3.00 -66.00 -4.00 -4.00 -48.00 -54.00 -40.00 -11.00
Capital Expenditure
-3.00 -4.00 -9.00 -4.00 -3.00 -7.00 -4.00 -4.00 -4.00 -4.00 -3.00 -3.00 -18.00 -8.00
Purchases of Investments
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Sale/Maturity of Investment
- - 7.00 - - - - - - - - - - - - - - - - - - - - - - - -
Property, Plant, Equipment (P&PE)
-3.00 -4.00 -9.00 -4.00 -3.00 -7.00 -4.00 -4.00 -4.00 -4.00 -3.00 -3.00 -18.00 -8.00
Acquisitions (Net)
- - -20.00 - - - - - - - - - - -62.00 - - - - -45.00 -51.00 -23.00 -3.00
Other Investing Activities
- - - - - - - - - - - - 1.00 - - - - - - - - - - 1.00 1.00
Financing Activities
Used Cash (Net)
-24.00 -29.00 -27.00 -30.00 -28.00 -31.00 -30.00 -27.00 -27.00 -27.00 -15.00 -3.00 -31.00 -34.00
Debt Repayment
- - - - - - - - - - - - - - -1.00 -3.00 -4.00 -50.00 -57.00 -18.00 -35.00
Dividends Paid
-26.00 -29.00 -30.00 -31.00 -31.00 -32.00 -33.00 -33.00 -24.00 -21.00 -10.00 - - - - - -
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Financing Activities
1.00 - - 3.00 - - 2.00 1.00 2.00 62.00 - - -1.00 76.00 53.00 -12.00 - -
Cash Balances
Begin of Period
49.00 54.00 37.00 23.00 31.00 44.00 43.00 49.00 47.00 57.00 60.00 62.00 53.00 49.00
End of Period
54.00 37.00 23.00 31.00 44.00 43.00 49.00 47.00 57.00 59.00 62.00 53.00 49.00 81.00
Change
4.00 -16.00 -14.00 7.00 12.00 -1.00 6.00 -2.00 9.00 2.00 1.00 -8.00 -3.00 31.00
Non-Cash Balances
Depreciation and Amortization
4.00 4.00 5.00 6.00 5.00 5.00 5.00 6.00 8.00 7.00 9.00 13.00 15.00 16.00
Stock Based Compensation
1.00 1.00 2.00 1.00 2.00 3.00 3.00 2.00 3.00 3.00 3.00 3.00 4.00 6.00
Other
- - - - - - -2.00 - - 2.00 1.00 1.00 6.00 1.00 - - -4.00 -1.00 7.00
Highlighted metrics
Free Cash Flow (FCF)
28.00 26.00 13.00 37.00 41.00 31.00 38.00 33.00 36.00 30.00 32.00 44.00 48.00 73.00
Cash Conversion Cycle (CCC)
174.00 213.00 220.00 199.00 208.00 200.00 195.00 250.00 215.00 212.00 207.00 240.00 265.00 178.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows